ADAR1 Capital Management »

Ventyx Biosciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Ventyx Biosciences (VTYX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Ventyx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Ventyx Biosciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ventyx Biosciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $32k 13k 2.47

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Ventyx Biosciences

Citadel Advisors
Vanguard Group
Tang Capital Management
Logos Global Management
Millennium Management
Goldman Sachs Group
Opaleye Management
Two Sigma Investments
Two Sigma Advisers
Qiming U.S. Ventures Management
Marshall Wace
D. E. Shaw & Co
Graham Capital Management
Jane Street
LMR Partners

View all funds holding Ventyx Biosciences